Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 Sep-Oct;6(5):534–536. doi: 10.3201/eid0605.000514

Fecal colonization with vancomycin-resistant enterococci in Australia.

A A Padiglione 1, E A Grabsch 1, D Olden 1, M Hellard 1, M I Sinclair 1, C K Fairley 1, M L Grayson 1
PMCID: PMC2627949  PMID: 11202974

Abstract

To assess the rate of fecal vancomycin-resistant enterococci (VRE) colon ization in Austalia, we examined specimens from 1,085 healthy volunteers. VRE was cultured from 2(0.2%) of 1,085 specimens; both were vanB Enter ococcus faecium, identical by pulsed-field gel electrophoresis, but with a pattern rare in Melbourne hospitals.

Full Text

The Full Text of this article is available as a PDF (20.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell J. M., Paton J. C., Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol. 1998 Aug;36(8):2187–2190. doi: 10.1128/jcm.36.8.2187-2190.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Coque T. M., Tomayko J. F., Ricke S. C., Okhyusen P. C., Murray B. E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996 Nov;40(11):2605–2609. doi: 10.1128/aac.40.11.2605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995 Jan;33(1):24–27. doi: 10.1128/jcm.33.1.24-27.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eliopoulos G. M. Vancomycin-resistant enterococci. Mechanism and clinical relevance. Infect Dis Clin North Am. 1997 Dec;11(4):851–865. doi: 10.1016/s0891-5520(05)70393-7. [DOI] [PubMed] [Google Scholar]
  5. Endtz H. P., van den Braak N., van Belkum A., Kluytmans J. A., Koeleman J. G., Spanjaard L., Voss A., Weersink A. J., Vandenbroucke-Grauls C. M., Buiting A. G. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol. 1997 Dec;35(12):3026–3031. doi: 10.1128/jcm.35.12.3026-3031.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Facklam R. R., Collins M. D. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989 Apr;27(4):731–734. doi: 10.1128/jcm.27.4.731-734.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grayson M. L., Grabsch E. A., Johnson P. D., Olden D., Aberline M., Li H. Y., Hogg G., Abbott M., Kerr P. G. Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria. Med J Aust. 1999 Aug 2;171(3):133–136. doi: 10.5694/j.1326-5377.1999.tb123564.x. [DOI] [PubMed] [Google Scholar]
  8. Hellard M. E., Sinclair M. I., Hogg G. G., Fairley C. K. Prevalence of enteric pathogens among community based asymptomatic individuals. J Gastroenterol Hepatol. 2000 Mar;15(3):290–293. doi: 10.1046/j.1440-1746.2000.02089.x. [DOI] [PubMed] [Google Scholar]
  9. McManus P., Hammond M. L., Whicker S. D., Primrose J. G., Mant A., Fairall S. R. Antibiotic use in the Australian community, 1990-1995. Med J Aust. 1997 Aug 4;167(3):124–127. doi: 10.5694/j.1326-5377.1997.tb138809.x. [DOI] [PubMed] [Google Scholar]
  10. Miranda A. G., Singh K. V., Murray B. E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol. 1991 Dec;29(12):2752–2757. doi: 10.1128/jcm.29.12.2752-2757.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murray B. E. The life and times of the Enterococcus. Clin Microbiol Rev. 1990 Jan;3(1):46–65. doi: 10.1128/cmr.3.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Van der Auwera P., Pensart N., Korten V., Murray B. E., Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996 May;173(5):1129–1136. doi: 10.1093/infdis/173.5.1129. [DOI] [PubMed] [Google Scholar]
  13. Wegener H. C., Aarestrup F. M., Jensen L. B., Hammerum A. M., Bager F. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis. 1999 May-Jun;5(3):329–335. doi: 10.3201/eid0503.990303. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES